Back to search

University of British Columbia

Role of endothelial heparanase in cardiac growth and metabolism and changes following diabetes

Abstract

dc:description

Endothelial cells (EC) influence subjacent cardiomyocyte metabolism and growth. Heparanase (Hpa), with exclusive expression in ECs, enables translocation of lipoprotein lipase (LPL) to the vascular lumen for hydrolysis of lipoprotein triglyceride, generating energy for cardiac contraction. We determined whether flow-mediated biophysical forces can cause EC to secrete Hpa. Despite the abundance of enzymatically active Hpa in the heart, it was the enzymatically inactive, latent Hpa that was exceptionally responsive to flow-induced release. EC exposed to orbital rotation exhibited a similar pattern of Hpa secretion, an effect that was reproduced by activation of the mechanosensor, Piezo1. The flow-mediated release of Hpa from EC required activation of both the purinergic receptor and protein kinase D. Hpa influenced cardiac metabolism by increasing cardiomyocyte LPL displacement along with subsequent replenishment. Flow-induced Hpa secretion was augmented following diabetes, and could explain the increased pool of LPL at the coronary lumen in these diabetic hearts. Hpa also facilitates angiogenesis, metabolic reprogramming, and cell survival, an environment favorable for cardiomyocyte growth. Hpa overexpression resulted in physiological cardiac hypertrophy, likely an outcome on HSPG clustering and activation of hypertrophic signaling. The autocrine effect of Hpa to release neuregulin-1 (NRG-1) may have also contributed to this effect. Hyperglycemia induced by streptozotocin-diabetes sensitized the heart to flow-induced release of Hpa and NRG-1. Despite this excess secretion, progression of diabetes caused significant gene expression changes related to mitochondrial metabolism and cell death that led to development of pathological cardiac hypertrophy. Physiological cardiac hypertrophy was also observed in rats with VEGFB overexpression. When perfused, hearts from these animals released significantly higher amounts of both Hpa and NRG-1. However, subjecting these animals to diabetes triggered robust genomic changes related to metabolism, and a transition to pathological hypertrophy. Overall, flow-induced mechanosensing and its dynamic control of cardiac metabolism to generate ATP is exquisitely adapted to respond to disease conditions, like diabetes. Additionally, we establish another novel function of Hpa to promote physiological cardiac hypertrophy. In the absence of mechanisms that support cardiac energy generation and prevention of cell death, as seen following diabetes, there is a transition from physiological to pathological cardiac hypertrophy.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Pharmaceutical Sciences
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lee, Chae Syng
Contributors dc:contributor
  • Rodrigues, Brian

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/88980

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Lee, Chae Syng. Role of endothelial heparanase in cardiac growth and metabolism and changes following diabetes. doctoral thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/88980